Correlation Between Celestica and Regeneron Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Celestica and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Celestica and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Celestica and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on Celestica and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Celestica with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Celestica and Regeneron Pharmaceuticals.
Diversification Opportunities for Celestica and Regeneron Pharmaceuticals
-0.96 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Celestica and Regeneron is -0.96. Overlapping area represents the amount of risk that can be diversified away by holding Celestica and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and Celestica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Celestica are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of Celestica i.e., Celestica and Regeneron Pharmaceuticals go up and down completely randomly.
Pair Corralation between Celestica and Regeneron Pharmaceuticals
Considering the 90-day investment horizon Celestica is expected to generate 2.02 times more return on investment than Regeneron Pharmaceuticals. However, Celestica is 2.02 times more volatile than Regeneron Pharmaceuticals. It trades about 0.18 of its potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about -0.14 per unit of risk. If you would invest 8,667 in Celestica on September 27, 2024 and sell it today you would earn a total of 1,086 from holding Celestica or generate 12.53% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Celestica vs. Regeneron Pharmaceuticals
Performance |
Timeline |
Celestica |
Regeneron Pharmaceuticals |
Celestica and Regeneron Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Celestica and Regeneron Pharmaceuticals
The main advantage of trading using opposite Celestica and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Celestica position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.Celestica vs. Quantum Computing | Celestica vs. IONQ Inc | Celestica vs. Quantum | Celestica vs. Arista Networks |
Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |